Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA.
Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55902, USA.
Abdom Radiol (NY). 2018 Feb;43(2):253-263. doi: 10.1007/s00261-017-1380-4.
Pancreatic adenocarcinoma is a common malignancy that has a poor prognosis. Imaging is vital in its detection, staging, and management. Although a variety of imaging techniques are available, MDCT is the preferred imaging modality for staging and assessing the resectability of pancreatic adenocarcinoma. MR also has an important adjunct role, and may be used in addition to CT or as a problem-solving tool. A dedicated pancreatic protocol should be acquired as a biphasic technique optimized for the detection of pancreatic adenocarcinoma and to allow accurate local and distant disease staging. Emerging techniques like dual-energy CT and texture analysis of CT and MR images have a great potential in improving lesion detection, characterization, and treatment monitoring.
胰腺腺癌是一种常见的恶性肿瘤，预后不良。影像学检查在其检测、分期和治疗中至关重要。虽然有多种影像学技术可供选择，但 MDCT 是分期和评估胰腺腺癌可切除性的首选影像学方法。MR 也具有重要的辅助作用，可与 CT 联合使用，也可作为解决问题的工具。应获取专门的胰腺协议，作为双相技术，优化用于检测胰腺腺癌，并允许准确的局部和远处疾病分期。新兴技术，如双能 CT 和 CT 及 MR 图像纹理分析，在提高病变检测、特征描述和治疗监测方面具有巨大潜力。
